Methods for treating cancer with bispecific anti-CD3xMUC16 antibodies and anti-PD-1 antibodies
MDE20250477A1Undetermined Publication Date: 2025-07-31REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MDE20250477T
- Authority / Receiving Office
- MD · MD
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2018-06-21
- Filing Date
- 2019-06-20
- Publication Date
- 2025-07-31
Need to check novelty before this filing date? Find Prior Art
No text content released.